Unaudited Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Treasury Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)	Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2022		172,560,916
Beginning balance at Dec. 31, 2022	$ 325,461	$ 18	$ 0	$ 509,094	$ (190,418)	$ 693	$ 6,074
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon release of restricted stock units (in shares)		1,464,968
Tax withholding related to vesting of restricted stock units (in shares)		(326,812)
Tax withholding related to vesting of restricted stock units	(557)			(557)
Issuance of common stock upon exercise of vested options (in shares)		117,215
Issuance of common stock upon exercise of vested options	61			61
Repurchase of early exercised stock options (in shares)		(8,132)
Vesting of early exercised stock options and restricted stock awards	131			131
Stock-based compensation expense	7,401			7,401
Net loss	(21,261)				(21,188)		(73)
Foreign-currency translation adjustment	228					137	91
Ending balance (in shares) at Mar. 31, 2023		173,808,155
Ending balance at Mar. 31, 2023	311,464	$ 18	0	516,130	(211,606)	830	6,092
Beginning balance (in shares) at Dec. 31, 2022		172,560,916
Beginning balance at Dec. 31, 2022	325,461	$ 18	0	509,094	(190,418)	693	6,074
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of early exercised stock options and restricted stock awards	225
Net loss	(65,318)
Foreign-currency translation adjustment	(158)
Ending balance (in shares) at Sep. 30, 2023		175,173,113
Ending balance at Sep. 30, 2023	285,550	$ 18	0	534,659	(254,843)	601	5,115
Beginning balance (in shares) at Mar. 31, 2023		173,808,155
Beginning balance at Mar. 31, 2023	311,464	$ 18	0	516,130	(211,606)	830	6,092
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon release of restricted stock units (in shares)		243,473
Issuance of common stock upon exercise of vested options (in shares)		335,085
Issuance of common stock upon exercise of vested options	269			269
Vesting of early exercised stock options and restricted stock awards	67			67
Stock-based compensation expense	8,809			8,809
Net loss	(25,100)				(24,889)		(211)
Foreign-currency translation adjustment	(53)					(32)	(21)
Ending balance (in shares) at Jun. 30, 2023		174,386,713
Ending balance at Jun. 30, 2023	295,456	$ 18	0	525,275	(236,495)	798	5,860
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon release of restricted stock units (in shares)		740,880
Issuance of common stock upon exercise of vested options (in shares)		239,920
Issuance of common stock upon exercise of vested options	124			124
Repurchase of early exercised stock options (in shares)		(194,400)
Vesting of early exercised stock options and restricted stock awards	27			27
Stock-based compensation expense	9,233			9,233
Net loss	(18,957)				(18,348)		(609)
Foreign-currency translation adjustment	(333)					(197)	(136)
Ending balance (in shares) at Sep. 30, 2023		175,173,113
Ending balance at Sep. 30, 2023	$ 285,550	$ 18	0	534,659	(254,843)	601	5,115
Beginning balance (in shares) at Dec. 31, 2023	176,899,814	176,899,814
Beginning balance at Dec. 31, 2023	$ 268,418	$ 18	(625)	543,846	(280,638)	911	4,906
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon release of restricted stock units (in shares)		3,866,866
Tax withholding related to vesting of restricted stock units (in shares)		(1,073,222)
Tax withholding related to vesting of restricted stock units	(2,302)			(2,302)
Issuance of common stock upon exercise of vested options (in shares)		317,769
Issuance of common stock upon exercise of vested options	227			227
Vesting of early exercised stock options and restricted stock awards	36			36
Stock-based compensation expense	9,467			9,467
Net loss	(18,994)				(18,624)		(370)
Foreign-currency translation adjustment	(255)					(146)	(109)
Ending balance (in shares) at Mar. 31, 2024		180,011,227
Ending balance at Mar. 31, 2024	$ 256,597	$ 18	(625)	551,274	(299,262)	765	4,427
Beginning balance (in shares) at Dec. 31, 2023	176,899,814	176,899,814
Beginning balance at Dec. 31, 2023	$ 268,418	$ 18	(625)	543,846	(280,638)	911	4,906
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of early exercised stock options and restricted stock awards	107
Net loss	(51,878)
Foreign-currency translation adjustment	$ 57
Ending balance (in shares) at Sep. 30, 2024	184,320,636	184,320,636
Ending balance at Sep. 30, 2024	$ 238,281	$ 19	(625)	565,529	(331,328)	933	3,753
Beginning balance (in shares) at Mar. 31, 2024		180,011,227
Beginning balance at Mar. 31, 2024	256,597	$ 18	(625)	551,274	(299,262)	765	4,427
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon release of restricted stock units (in shares)		3,057,758
Issuance of common stock upon release of restricted stock units	0	$ 1		(1)
Tax withholding related to vesting of restricted stock units (in shares)		(563,421)
Tax withholding related to vesting of restricted stock units	(1,135)			(1,135)
Issuance of common stock upon exercise of vested options (in shares)		174,659
Issuance of common stock upon exercise of vested options	234			234
Repurchase of early exercised stock options (in shares)		(10,149)
Vesting of early exercised stock options and restricted stock awards	35			35
Stock-based compensation expense	7,859			7,859
Net loss	(14,040)				(13,724)		(316)
Foreign-currency translation adjustment	(76)					(44)	(32)
Ending balance (in shares) at Jun. 30, 2024		182,670,074
Ending balance at Jun. 30, 2024	249,474	$ 19	(625)	558,266	(312,986)	721	4,079
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon release of restricted stock units (in shares)		1,936,564
Tax withholding related to vesting of restricted stock units (in shares)		(308,725)
Tax withholding related to vesting of restricted stock units	(406)			(406)
Issuance of common stock upon exercise of vested options (in shares)		22,723
Issuance of common stock upon exercise of vested options	12			12
Vesting of early exercised stock options and restricted stock awards	35			35
Stock-based compensation expense	7,622			7,622
Net loss	(18,844)				(18,342)		(502)
Foreign-currency translation adjustment	$ 388					212	176
Ending balance (in shares) at Sep. 30, 2024	184,320,636	184,320,636
Ending balance at Sep. 30, 2024	$ 238,281	$ 19	$ (625)	$ 565,529	$ (331,328)	$ 933	$ 3,753